These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34289832)

  • 61. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
    Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
    Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
    Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
    J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
    [TBL] [Abstract][Full Text] [Related]  

  • 63. miR-29a-3p promotes migration and invasion in ameloblastoma via Wnt/β-catenin signaling by targeting catenin beta interacting protein 1.
    Liu S; Liu D; Liu J; Liu J; Zhong M
    Head Neck; 2021 Dec; 43(12):3911-3921. PubMed ID: 34636093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-cancer effect of miR-139-3p on laryngeal squamous cell carcinoma by targeting rab5a: In vitro and in vivo studies.
    Ma Y; Gong Z; Wang H; Liang Y; Huang X; Yu G
    Pathol Res Pract; 2020 Nov; 216(11):153194. PubMed ID: 32916448
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Yu G; Jia Z; Dou Z
    Oncol Rep; 2017 Feb; 37(2):1123-1131. PubMed ID: 28000900
    [TBL] [Abstract][Full Text] [Related]  

  • 66. miR-145 inhibits invasion of bladder cancer cells by targeting PAK1.
    Kou B; Gao Y; Du C; Shi Q; Xu S; Wang CQ; Wang X; He D; Guo P
    Urol Oncol; 2014 Aug; 32(6):846-54. PubMed ID: 24954107
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
    Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. microRNA-29a-3p, Up-Regulated in Human Gastric Cells and Tissues with H.Pylori Infection, Promotes the Migration of GES-1 Cells via A20-Mediated EMT Pathway.
    Sun F; Ni Y; Zhu H; Fang J; Wang H; Xia J; Ding F; Shen H; Shao S
    Cell Physiol Biochem; 2018; 51(3):1250-1263. PubMed ID: 30485838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.
    Ji Q; Xu X; Song Q; Xu Y; Tai Y; Goodman SB; Bi W; Xu M; Jiao S; Maloney WJ; Wang Y
    Mol Ther; 2018 May; 26(5):1299-1312. PubMed ID: 29628305
    [TBL] [Abstract][Full Text] [Related]  

  • 71. hsa_circ_0001610 knockdown modulates miR-646-STAT3 axis to suppress endometrial carcinoma progression.
    Wang B; Lu Y; Feng E
    J Gene Med; 2021 Jun; 23(6):e3337. PubMed ID: 33822442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. lncRNA IGKJ2-MALLP2 suppresses LSCC proliferation, migration, invasion, and angiogenesis by sponging miR-1911-3p/p21.
    Cao J; Yang Z; An R; Zhang J; Zhao R; Li W; Xu L; Sun Y; Liu M; Tian L
    Cancer Sci; 2020 Sep; 111(9):3245-3257. PubMed ID: 32639636
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function.
    Zhou C; Zou QY; Li H; Wang RF; Liu AX; Magness RR; Zheng J
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3470-3479. PubMed ID: 28911139
    [TBL] [Abstract][Full Text] [Related]  

  • 74. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
    BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
    Wang Y; Dong L; Liu Y
    Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
    [No Abstract]   [Full Text] [Related]  

  • 77. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 78. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
    Lu M; Ding N; Zhuang S; Li Y
    Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
    Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
    Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.